New issues on measurement of B-type natriuretic peptides
Open Access
- 15 August 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 56 (1) , 32-39
Abstract
The measurement of the active hormone of B-type natriuretic peptide (BNP) system actually has several analytical limitations and difficulties in clinical interpretations compared to that of inactive peptide N-terminal proBNP (NT-proBNP) because of the different biochemical and pathophysiological characteristics of two peptides and quality specifications of commercial immunoassay methods used for their measurement. Because of the better analytical characteristics of NT-proBNP immunoassays and the easier pathophysiological and clinical interpretations of variations of NT-proBNP levels in patients with heart failure (HF), some authors claimed to measure the inactive peptide NT-proBNP instead of the active hormone BNP for management of HF patients. The measurement of the active peptide hormone BNP gives different, but complementary, pathophysiological and clinical information compared to inactive NT-proBNP. In particular, the setup of new more sensitive and specific assays for the biologically active peptide BNP1-32 should give better accurate information on circulating natriuretic activity. In conclusion, at present time, clinicians should accurately consider both the clinical setting of patients and the analytical characteristics of BNP and NT-proBNP immunoassays in order to correctly interpret the variations of natriuretic peptides measured by commercially available laboratory methods, especially in patients treated with the new drug class of angiotensin receptor-neprilysin inhibitors.Keywords
This publication has 57 references indexed in Scilit:
- Systematic differences between BNP immunoassays: Comparison of methods using standard protocols and quality control materialsClinica Chimica Acta, 2013
- Ectodomain Shedding and Autocleavage of the Cardiac Membrane Protease CorinJournal of Biological Chemistry, 2011
- Insulin-degrading Enzyme Modulates the Natriuretic Peptide-mediated Signaling ResponseJournal of Biological Chemistry, 2011
- Plasma Soluble Corin in Patients With Heart FailureCirculation: Heart Failure, 2010
- Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trialsAmerican Heart Journal, 2009
- Detection of Endogenous B-Type Natriuretic Peptide at Very Low Concentrations in Patients With Heart FailureCirculation: Heart Failure, 2008
- Immunodetection of Glycosylated NT-proBNP Circulating in Human BloodClinical Chemistry, 2008
- Analysis of Circulating Forms of proBNP and NT-proBNP in Patients with Severe Heart FailureClinical Chemistry, 2008
- Elecsys NT-ProBNP and BNP Assays: Are There Analytically and Clinically Relevant Differences?Journal of Cardiac Failure, 2005
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981